A detailed history of Schonfeld Strategic Advisors LLC transactions in Repligen Corp stock. As of the latest transaction made, Schonfeld Strategic Advisors LLC holds 4,259 shares of RGEN stock, worth $607,248. This represents 0.0% of its overall portfolio holdings.

Number of Shares
4,259
Previous 7,924 46.25%
Holding current value
$607,248
Previous $998,000 36.57%
% of portfolio
0.0%
Previous 0.01%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$119.79 - $167.35 $439,030 - $613,337
-3,665 Reduced 46.25%
4,259 $633,000
Q2 2024

Aug 14, 2024

BUY
$120.0 - $182.95 $950,880 - $1.45 Million
7,924 New
7,924 $998,000
Q4 2023

Feb 14, 2024

BUY
$114.17 - $185.35 $1.14 Million - $1.84 Million
9,943 New
9,943 $1.79 Million
Q2 2023

Aug 14, 2023

BUY
$138.42 - $180.31 $1.48 Million - $1.93 Million
10,703 Added 248.91%
15,003 $2.12 Million
Q1 2023

May 15, 2023

SELL
$154.26 - $198.1 $852,286 - $1.09 Million
-5,525 Reduced 56.23%
4,300 $723,000
Q4 2022

Feb 14, 2023

SELL
$162.42 - $220.56 $183,697 - $249,453
-1,131 Reduced 10.32%
9,825 $1.66 Million
Q3 2022

Nov 14, 2022

BUY
$160.42 - $256.21 $1.76 Million - $2.81 Million
10,956 New
10,956 $2.05 Million
Q1 2022

May 16, 2022

SELL
$161.19 - $257.96 $375,572 - $601,046
-2,330 Closed
0 $0
Q4 2021

Feb 14, 2022

SELL
$247.59 - $304.47 $122,557 - $150,712
-495 Reduced 17.52%
2,330 $617,000
Q3 2021

Nov 16, 2021

BUY
$194.77 - $324.21 $550,225 - $915,893
2,825 New
2,825 $816,000
Q2 2021

Aug 16, 2021

SELL
$165.87 - $220.95 $323,612 - $431,073
-1,951 Closed
0 $0
Q1 2021

May 17, 2021

BUY
$180.37 - $226.26 $351,901 - $441,433
1,951 New
1,951 $379,000
Q3 2020

Nov 16, 2020

SELL
$122.51 - $158.27 $420,699 - $543,499
-3,434 Closed
0 $0
Q2 2020

Aug 14, 2020

BUY
$94.33 - $140.48 $323,929 - $482,408
3,434 New
3,434 $424,000
Q4 2019

Feb 14, 2020

SELL
$73.84 - $93.08 $361,816 - $456,092
-4,900 Closed
0 $0
Q3 2019

Nov 14, 2019

BUY
$76.65 - $95.51 $375,585 - $467,999
4,900 New
4,900 $376,000
Q1 2019

May 15, 2019

SELL
$49.45 - $62.8 $835,507 - $1.06 Million
-16,896 Closed
0 $0
Q4 2018

Feb 14, 2019

BUY
$48.26 - $68.88 $815,400 - $1.16 Million
16,896 New
16,896 $891,000
Q3 2018

Nov 14, 2018

SELL
$46.8 - $58.97 $1.37 Million - $1.73 Million
-29,300 Closed
0 $0
Q2 2018

Aug 14, 2018

BUY
$35.26 - $47.04 $1.03 Million - $1.38 Million
29,300 New
29,300 $1.38 Million

Others Institutions Holding RGEN

About REPLIGEN CORP


  • Ticker RGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 55,491,200
  • Market Cap $7.91B
  • Description
  • Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....
More about RGEN
Track This Portfolio

Track Schonfeld Strategic Advisors LLC Portfolio

Follow Schonfeld Strategic Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Schonfeld Strategic Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Schonfeld Strategic Advisors LLC with notifications on news.